Health Policy in 2025: Changes for U.S. and U.K. Digital Health and Life Sciences Industries

Following the 2024 elections, both the United States and the United Kingdom ushered in new governments, bringing with them fresh health care policy priorities impacting digital health and life science companies. Join leading health lawyers and policy advisors from Manatt Health and DAC Beachcroft for an in-depth discussion on the evolving policy landscape and its potential impact on the digital health, life sciences and broader health care sectors operating in both markets.
Key Topics Include:
- How companies in the U.S. and U.K. can prepare for policy change in both countries
- What sectors of the health industry are most likely to interest the new governments
- How to think about policy in times of shifting politics
Moderator:
- , Managing Director, Manatt Health, New York
Panelists:
U.S.
- , Partner, Manatt Health, New York
- , Managing Director, Manatt Health, Washington, D.C.
- , Partner, Manatt Health, New York
U.K.
- Hamza Drabu, Head of Health, DAC Beachcroft, London
- Darryn Hale, Partner, Health Information Law, DAC Beachcroft, London
- Alison McAdams, Head of Life Sciences, DAC Beachcroft, London
Date and Time
Thursday, March 13
12:00 p.m. - 1:00 p.m. ET
9:00 a.m. - 10:00 a.m. PT